Evidence map›Paper›PMID 20472591›Full record

SynthesisAnnals of the rheumatic diseases2010

Association of variation in Fcgamma receptor 3B gene copy number with rheumatoid arthritis in Caucasian samples.

Cushla McKinney, Manuela Fanciulli, Marilyn E Merriman, Amanda Phipps-Green, Behrooz Z Alizadeh, Bobby P C Koeleman, Nicola Dalbeth, Peter J Gow, Andrew A Harrison, John Highton and 11 more

Open access · greenAbstract readMeta-AnalysisMulticenter Study
In one paragraph

Synthesis in Annals of the rheumatic diseases, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 5 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 5 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Association between FCGR3B copy number variations and susceptibility to autoimmune diseases: a meta-analysis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2015
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. The Immunogenetics of Systemic Sclerosis.Advances in experimental medicine and biology · 2022
    Article
  10. Review
  11. Association ofDisease markers · 2020
    Article
  12. Genetic Polymorphisms onFrontiers in psychiatry · 2020
    Article
  13. Review
  14. The Oxytocin Receptor Gene (Frontiers in psychology · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Leukocyte-specific protein 1 regulates T-cell migration in rheumatoid arthritis.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 4 countries.

Cushla McKinneyDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
Manuela Fanciulli
Marilyn E Merriman
Amanda Phipps-Green
Behrooz Z Alizadeh
Bobby P C Koeleman
Nicola Dalbeth
Peter J Gow
Andrew A Harrison
John Highton
Peter B Jones
Lisa K Stamp
Sophia Steer
Pilar Barrera
Marieke J H Coenen
Barbara Franke
Piet L C M van Riel
Tim J Vyse
Tim J Aitman
Timothy R D J Radstake
Tony R Merriman
University of Otago · NZRadboud University Medical Center · NLImperial College London · GBUniversity of Auckland · NZUtrecht University · NLKing's College Hospital NHS Foundation Trust · GBMiddlemore Hospital · NZRadboud University Nijmegen · NL

Funding

Medical Research Council MC_U120061454Wellcome Trust 083167
6 · The paper itself

Abstract

objectiveThere is increasing evidence that variation in gene copy number (CN) influences clinical phenotype. The low-affinity Fcgamma receptor 3B (FCGR3B) located in the FCGR gene cluster is a CN polymorphic gene involved in the recruitment to sites of inflammation and activation of polymorphonuclear neutrophils (PMNs). Given recent evidence that low FCGR3B CN is a risk factor for systemic but not organ-specific autoimmune disease and the potential importance of PMN in the pathophysiology of rheumatoid arthritis (RA), the authors hypothesised that FCGR3B gene dosage influences susceptibility to RA.

methodsFCGR3B CN was measured in 643 cases of RA and 461 controls from New Zealand (NZ), with follow-up analysis in 768 cases and 702 controls from the Netherlands and 250 cases and 211 controls from the UK. All subjects were of Caucasian ancestry.

resultsSignificant evidence for an association between CN <2 and RA was observed in the Dutch cohort (OR 2.01 (95% CI 1.37 to 2.94), p=3 x 10-4) but not in the two smaller cohorts (OR 1.45 (95% CI 0.92 to 2.26), p=0.11 and OR 1.33 (95% CI 0.58 to 3.02), p=0.50 for the NZ and UK populations, respectively). The association was evident in a meta-analysis which included a previously published Caucasian sample set (OR 1.67 (95% CI 1.28 to 2.17), p=1.2 x 10-4).

conclusionsOne possible mechanism to explain the association between reduced FCGR3B CN and RA is the reduced clearance of immune complex during inflammation. However, it is not known whether the association between RA and FCGR3B CN is aetiological or acts as a proxy marker for another biologically relevant variant. More detailed examination of genetic variation within the FCGR gene cluster is required.

Indexed as

AdolescentAdultAgedAged, 80 and overArthritis, RheumatoidCase-Control StudiesFemaleGene DosageGenetic Predisposition to DiseaseGPI-Linked ProteinsHumansMaleMiddle AgedReceptors, IgGYoung AdultFCGR3B protein, humanGPI-Linked ProteinsReceptors, IgG

Identifiers

PMID20472591
PMCPMC3670580
OpenAlexW2136367522

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.